Cytarabine
Sold as Cytarabine-faulding, P & u cytarabine csv, Laracit, Cipla cytarabine ( ), Cytosar, Alexan
4-Amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one
Drag to rotate. Structure from PubChem CID 6253.
Background
Registration
- Applicants
- 6
- Registrations
- 14
- Schedule source
- Consolidated Schedules 06 July 2026
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Pharmaplan (Pty) Ltd1 of 2 cancelled | Cytarabine-faulding | 20 mg/ml, 100 mg/ml | 290360, 290361 | S4 | None |
| Pfizer Laboratories (Pty) Ltd1 of 4 cancelled | P & u cytarabine csv, Cytosar | 100 mg/5 ml, 500 mg / 25 ml, 500 mg, 1000 mg | 290499, 300308, T0047, T0048 | S4 | None |
| Teva Pharmaceuticals (Pty) LtdCancelled | Laracit | 100 mg, 500 mg | 370487, 370488 | S4 | None |
| Cipla Medpro (Pty) LtdCancelled | Cipla cytarabine ( ) | 5 ml 100, 10 ml 100, 100 mg 1 ml | A390452, A390453, A390454 | S4 | None |
| Pharmacia South Africa (Pty) Ltd | Cytosar | 100 mg | H2757 | S4 | None |
| Adcock ingram limitedCancelled | Alexan | 100 mg, 500 mg | T0083, T0161 | S4 | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Cytarabine-faulding 20 mg/ml EACH 1 ml CONTAINS CYTARABINE 20 mg | 20 mg/ml | 29036029/26/0360 | Cancelled | S4 | None |
| Cytarabine-faulding 100 mg/ml EACH 1 ml CONTAINS CYTARABINE 100 mg | 100 mg/ml | 29036129/26/0361 | Registered | S4 | None |
| P & u cytarabine csv 100 mg/5 ML injection EACH 1 ml SOLUTION CONTAINS CYTARABINE 20 mg | 100 mg/5 mlInjection | 29049929/26/0499 | Registered | S4 | None |
| P & u cytarabine csv 500 MG / 25 ML injection EACH 1 ml SOLUTION CONTAINS CYTARABINE 20 mg | 500 mg / 25 mlInjection | 30030830/26/0308 | Registered | S4 | None |
| Laracit 100 MG EACH VIAL CONTAINS CYTARABINE 100,0 mg | 100 mg | 37048737/26/0487 | Cancelled | S4 | None |
| Laracit 500 MG EACH VIAL CONTAINS CYTARABINE 500,0 mg | 500 mg | 37048837/26/0488 | Cancelled | S4 | None |
| Cipla cytarabine injection 100 MG (1 ml) EACH 1,0 ml SOLUTION CONTAINS CYTARABINE 100,0 mg | 100 mg 1 mlInjection | A390452A39/26/0452 | Cancelled | S4 | None |
| Cipla cytarabine injection 100 (5 ml) EACH 1,0 ml SOLUTION CONTAINS CYTARABINE 100,0 mg | 5 ml 100Injection | A390453A39/26/0453 | Cancelled | S4 | None |
| Cipla cytarabine injection 100 (10 ml) EACH 1,0 ml SOLUTION CONTAINS CYTARABINE 100,0 mg | 10 ml 100Injection | A390454A39/26/0454 | Cancelled | S4 | None |
| Cytosar 100 MG EACH VIAL CONTAINS CYTARABINE A 100 mg | 100 mg | H2757 | Old Medicine | S4 | None |
| Cytosar 500 MG EACH VIAL CONTAINS CYTARABINE 500 mg | 500 mg | T0047T/26/47 | Registered | S4 | None |
| Cytosar 1000 MG EACH VIAL CONTAINS CYTARABINE 1000 mg | 1000 mg | T0048T/26/48 | Cancelled | S4 | None |
| Alexan 100 MG EACH 5 ml CONTAINS CYTARABINE 100 mg | 100 mg | T0083T/26/83 | Cancelled | S4 | None |
| Alexan 500 MG EACH 10 ml VIAL CONTAINS CYTARABINE 500 mg | 500 mg | T0161T/26/161 | Cancelled | S4 | None |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Cytarabine
S4: Cytarabine
Consolidated Schedules 06 July 2026, line 5918
Pharmacological class: Cytostatic agents (class 26)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.